473732-65-9

Basic information

• Product Name: Benzenemethanamine, a-ethyl-4-phenoxy-
• Synonyms: 1-(4-phenoxyphenyl)propan-1-amine
• CAS NO: 473732-65-9
• Molecular Formula: C₁₅H₁₇NO
• Molecular Weight: 227.30158
• Mol File: 473732-65-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzenemethanamine, a-ethyl-4-phenoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanamine, a-ethyl-4-phenoxy-(473732-65-9)
• EPA Substance Registry System: Benzenemethanamine, a-ethyl-4-phenoxy-(473732-65-9)

Safety Data

• Hazardous Substances Data: 473732-65-9(Hazardous Substances Data)

Upstream product

• 108-95-2 phenol 
• 889-26-9 1-(4-phenoxyphenyl)propan-1-one 
• 456-03-1 1-(4-fluorophenyl)propan-1-one 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS

The present disclosure relates generally to compounds useful in treatment of conditions associated with mutant isocitrate dehydrogenase (mt-IDH), particularly mutant IDH1 enzymes. Specifically, the present invention discloses compound of formula (IA), which exhibits inhibitory activity against mutant IDH1 enzymes. Method of treating conditions associated with excessive activity of mutant IDH1 enzymes with such compound is disclosed. Uses thereof, pharmaceutical composition, and kits are also disclosed.

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.